Street Signs

SMART EYE

 Big Boy's games
There was a fair degree of action at Wyeth last week, which led to considerable upsides at the pharma counter. The perpetrators were mainly desi funds Big Boy and Prudent Fund.

 While the former bought 1.5 lakh shares of the scrip at Rs 500, the latter went a tad ahead, mopping up 4.3 lakh shares at the same price. Wyeth has been in the news of late, more for its real estate dealings rather than pharma operations.  The Rs 300-crore company, the Indian arm of the US-based drug maker, is into antibiotics, oral contraceptives and vaccines. Wyeth recently put its office property in Mumbai, valued at Rs 15 crore, on the block. This happened soon after it sold its manufacturing facility at Ghatkopar for Rs 40 crore. Now, before you come to any premature conclusions, all this is just a part of the company